Long-acting injectable PrEP is now to be covered without cost-sharing under Affordable Care Act rules, the Biden ...

Studies from OPERA and Trio cohorts provide further real-world evidence supporting CAB LA for PrEP’s high effectiveness and adherence in preventing HIV acquisition Patient-reported results for CAB LA ...

Interview - Research has shown that social behavior change is a cost-effective tool in HIV prevention, particularly when combined with robust advocacy efforts. When young people are equipped with ...

Oral PrEP drugs had been paid for under ... "We needed a way to cover the injectable HIV prevention drugs, and that's what necessitated the ask for the coverage determination," Schmid said in ...

Though, reproductive freedom legislation and regulations will ultimately equate to sexual freedoms and regulations. To be ...

Recommended Reading Twice-yearly shots of Gilead HIV drug effective in large ... global regulatory filings for lenacapavir as pre-exposure prophylaxis, or PrEP, by the end of 2024.

For example: Ask a new partner to get ... PrEP, which stands for pre-exposure prophylaxis, is a type of daily drug therapy that can prevent HIV infection. It's approved for people at very high ...

This is where we have a challenge with young people because they ask themselves what they ... the disease are also put on PrEP (antiretroviral medication by HIV-negative people, which reduces ...

The Council of State is tasked with deciding whether individuals who have had at least one homosexual relationship since 1977 ...

New long-acting technologies are changing the HIV prevention landscape. In recent years, innovation in pre-exposure prophylaxis (PrEP ... do not know how to ask for help, and often do not know their ...